MTOR and metabolic pathways in T cell quiescence and functional activation

Seminars in Immunology

Volumn 24, Issue 6, 2012, Pages 421-428

  Yang, Kai ^a   Chi, Hongbo ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CD4+ T cell differentiation; CD8+ memory T cell; MTOR; T cell metabolism; T cell quiescence

Indexed keywords

FATTY ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN KINASE LKB1;

ANTIGEN RECOGNITION; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL METABOLISM; FATTY ACID OXIDATION; GROWTH REGULATION; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL MEMORY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MITOCHONDRION; REVIEW; SIGNAL TRANSDUCTION; STEADY STATE; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; THYMOCYTE;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; THYMUS GLAND; TOR SERINE-THREONINE KINASES;

EID: 84874226167     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.12.004     Document Type: Review

References (83)

1. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews: Molecular Cell Biology 2011, 12:21-35.
2. Mieulet V., Lamb R.F. Tuberous sclerosis complex: linking cancer to metabolism. Trends in Molecular Medicine 2010, 16:329-335.
3. Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nature Reviews: Immunology 2012, 12:325-338.
4. Powell J.D., Delgoffe G.M. The mammalian target of rapamycin: linking T Cell differentiation, function, and metabolism. Immunity 2010, 33:301-311.
5. Jones R.G., Thompson C.B. Revving the engine: signal transduction fuels T cell activation. Immunity 2007, 27:173-178.
6. Pearce E.L. Metabolism in T cell activation and differentiation. Current Opinion in Immunology 2010, 22:314-320.
7. Michalek R.D., Rathmell J.C. The metabolic life and times of a T-cell. Immunological Reviews 2010, 236:190-202.
8. Jacobs S.R., Michalek R.D., Rathmell J.C. IL-7 is essential for homeostatic control of T cell metabolism in vivo. Journal of Immunology 2010, 184:3461-3469.
9. Pua H.H., He Y.W. Mitophagy in the little lymphocytes: an essential role for autophagy in mitochondrial clearance in T lymphocytes. Autophagy 2009, 5:745-746.
10. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901.
11. Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136:521-534.
12. Grohmann U., Bronte V. Control of immune response by amino acid metabolism. Immunological Reviews 2010, 236:243-264.
13. Zheng Y., Collins S.L., Lutz M.A., Allen A.N., Kole T.P., Zarek P.E., et al. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Journal of Immunology 2007, 178:2163-2170.
14. Zheng Y., Delgoffe G.M., Meyer C.F., Chan W., Powell J.D. Anergic T cells are metabolically anergic. Journal of Immunology 2009, 183:6095-6101.
15. Cobbold S.P., Adams E., Farquhar C.A., Nolan K.F., Howie D., Lui K.O., et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:12055-12060.
16. Duvel K., Yecies J.L., Menon S., Raman P., Lipovsky A.I., Souza A.L., et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell 2010, 39:171-183.
17. Cunningham J.T., Rodgers J.T., Arlow D.H., Vazquez F., Mootha V.K., Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007, 450:736-740.
18. reg cells. Journal of Experimental Medicine 2011, 208:1367-1376.
19. Wang R., Dillon C.P., Shi L.Z., Milasta S., Carter R., Finkelstein D., et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011, 35:871-882.
20. Carpenter A.C., Bosselut R. Decision checkpoints in the thymus. Nature Immunology 2010, 11:666-673.
21. Maillard I., Fang T., Pear W.S. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annual Review of Immunology 2005, 23:945-974.
22. Lee K., Nam K.T., Cho S.H., Gudapati P., Hwang Y., Park D.S., et al. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. Journal of Experimental Medicine 2012, 209:713-728.
23. Tang F., Wu Q., Ikenoue T., Guan K.L., Liu Y., Zheng P. A critical role for rictor in T lymphopoiesis. Journal of Immunology 2012, 189:1850-1857.
24. Song M.S., Salmena L., Pandolfi P.P. The functions and regulation of the PTEN tumour suppressor. Nature Reviews: Molecular Cell Biology 2012, 13:283-296.
25. Suzuki A., Yamaguchi M.T., Ohteki T., Sasaki T., Kaisho T., Kimura Y., et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 2001, 14:523-534.
26. Hagenbeek T.J., Naspetti M., Malergue F., Garcon F., Nunes J.A., Cleutjens K.B., et al. The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. Journal of Experimental Medicine 2004, 200:883-894.
27. Garcia-Cao I., Song M.S., Hobbs R.M., Laurent G., Giorgi C., de Boer V.C., et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 2012, 149:49-62.
28. Liu X., Karnell J.L., Yin B., Zhang R., Zhang J., Li P., et al. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. Journal of Clinical Investigation 2010, 120:2497-2507.
29. Finlay D.K., Sinclair L.V., Feijoo C., Waugh C.M., Hagenbeek T.J., Spits H., et al. Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes. Journal of Experimental Medicine 2009, 206:2441-2454.
30. Guo W., Schubbert S., Chen J.Y., Valamehr B., Mosessian S., Shi H., et al. Suppression of leukemia development caused by PTEN loss. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:1409-1414.
31. Kishimoto H., Ohteki T., Yajima N., Kawahara K., Natsui M., Kawarasaki S., et al. The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood 2007, 109:3316-3324.
32. Shackelford D.B., Shaw R.J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nature Reviews: Cancer 2009, 9:563-575.
33. Cao Y., Li H., Liu H., Zheng C., Ji H., Liu X. The serine/threonine kinase LKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression. Cell Research 2010, 20:99-108.
34. Cao Y., Li H., Liu H., Zhang M., Hua Z., Ji H., et al. LKB1 regulates TCR-mediated PLCgamma1 activation and thymocyte positive selection. EMBO Journal 2011, 30:2083-2093.
35. Tamas P., Macintyre A., Finlay D., Clarke R., Feijoo-Carnero C., Ashworth A., et al. LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells. European Journal of Immunology 2010, 40:242-253.
36. Maciver N.J., Blagih J., Saucillo D.C., Tonelli L., Griss T., Rathmell J.C., et al. The liver kinase b1 is a central regulator of T cell development, activation, and metabolism. Journal of Immunology 2011, 187:4187-4198.
37. Mayer A., Denanglaire S., Viollet B., Leo O., Andris F. AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. European Journal of Immunology 2008, 38:948-956.
38. Sprent J., Normal Surh C.D. T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nature Immunology 2011, 12:478-484.
39. Hamilton S.E., Jameson S.C. CD8 T cell quiescence revisited. Trends in Immunology 2012, 33:224-230.
40. Delgoffe G.M., Kole T.P., Zheng Y., Zarek P.E., Matthews K.L., Xiao B., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009, 30:832-844.
41. Yang K., Neale G., Green D.R., He W., Chi H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nature Immunology 2011, 12:888-897.
42. Wu Q., Liu Y., Chen C., Ikenoue T., Qiao Y., Li C.S., et al. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology 2011, 187:1106-1112.
43. O'Brien T.F., Gorentla B.K., Xie D., Srivatsan S., McLeod I.X., He Y.W., et al. Regulation of T-cell survival and mitochondrial homeostasis by TSC1. European Journal of Immunology 2011, 41:3361-3370.
44. + T cell survival and homeostasis in mice. PLoS One 2012, 7:e30592.
45. + T lymphocyte responses. Nature Immunology 2003, 4:361-365.
46. Xie D.L., Wu J., Lou Y.L., Zhong X.P. Tumor suppressor TSC1 is critical for T-cell anergy. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:14152-14157.
47. Michalek R.D., Gerriets V.A., Nichols A.G., Inoue M., Kazmin D., Chang C.Y., et al. Estrogen-related receptor-alpha is a metabolic regulator of effector T-cell activation and differentiation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:18348-18353.
48. Dang C.V., Kim J.W., Gao P., Yustein J. The interplay between MYC and HIF in cancer. Nature Reviews: Cancer 2008, 8:51-56.
49. Bensinger S.J., Bradley M.N., Joseph S.B., Zelcer N., Janssen E.M., Hausner M.A., et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008, 134:97-111.
50. + T cell lineage differentiation. Immunity 2009, 30:646-655.
51. + T cell subsets. Journal of Immunology 2011, 186:3299-3303.
52. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 2011, 12:295-303.
53. Lee K., Gudapati P., Dragovic S., Spencer C., Joyce S., Killeen N., et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 2010, 32:743-753.
54. Gao W., Lu Y., El Essawy B., Oukka M., Kuchroo V.K., Strom T.B. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. American Journal of Transplantation 2007, 7:1722-1732.
55. + regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. Journal of Leukocyte Biology 2008, 83:1230-1239.
56. + cells. Journal of Experimental Medicine 2008, 205:565-574.
57. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:7797-7802.
58. Liu G., Burns S., Huang G., Boyd K., Proia R.L., Flavell R.A., et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nature Immunology 2009, 10:769-777.
59. Liu G., Yang K., Burns S., Shrestha S., Chi H. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nature Immunology 2010, 11:1047-1056.
60. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. Journal of Experimental Medicine 2009, 206:3015-3029.
61. + regulatory T cells. Nature Immunology 2010, 11:618-627.
62. Harada Y., Elly C., Ying G., Paik J.H., DePinho R.A., Liu Y.C. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. Journal of Experimental Medicine 2010, 207:1381-1391.
63. Kerdiles Y.M., Stone E.L., Beisner D.L., McGargill M.A., Ch'en I.L., Stockmann C., et al. Foxo transcription factors control regulatory T cell development and function. Immunity 2010, 33:890-904.
64. Dang E.V., Barbi J., Yang H.Y., Jinasena D., Yu H., Zheng Y., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
65. Sundrud M.S., Koralov S.B., Feuerer M., Calado D.P., Kozhaya A.E., Rhule-Smith A., et al. Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science 2009, 324:1334-1338.
66. Cui G., Qin X., Wu L., Zhang Y., Sheng X., Yu Q., et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. Journal of Clinical Investigation 2011, 121:658-670.
67. Ahmed R., Bevan M.J., Reiner S.L., Fearon D.T. The precursors of memory: models and controversies. Nature Reviews: Immunology 2009, 9:662-668.
68. Araki K., Turner A.P., Shaffer V.O., Gangappa S., Keller S.A., Bachmann M.F., et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
69. + T cell fate by regulating the expression of transcription factors T-bet and eomesodermin. Immunity 2010, 32:67-78.
70. + T cell fate coupled by T-bet and eomesodermin. Nature Immunology 2005, 6:1236-1244.
71. Rosenfeldt H.M., Hobson J.P., Maceyka M., Olivera A., Nava V.E., Milstien S., et al. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. FASEB Journal 2001, 15:2649-2659.
72. Rao R.R., Li Q., Gubbels Bupp M.R., Shrikant P.A. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Immunity 2012, 36:374-387.
73. Pearce E.L., Walsh M.C., Cejas P.J., Harms G.M., Shen H., Wang L.S., et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009, 460:103-107.
74. + T cell memory development. Immunity 2012, 36:68-78.
75. Sinclair L.V., Finlay D., Feijoo C., Cornish G.H., Gray A., Ager A., et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nature Immunology 2008, 9:513-521.
76. Finlay D., Cantrell D.A. Metabolism, migration and memory in cytotoxic T cells. Nature Reviews: Immunology 2011, 11:109-117.
77. Kerdiles Y.M., Beisner D.R., Tinoco R., Dejean A.S., Castrillon D.H., DePinho R.A., et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nature Immunology 2009, 10:176-184.
78. Ouyang W., Beckett O., Flavell R.A., Li M.O. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 2009, 30:358-371.
79. Taqueti V.R., Grabie N., Colvin R., Pang H., Jarolim P., Luster A.D., et al. T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity. Journal of Immunology 2006, 177:5890-5901.
80. Kohlmeier J.E., Reiley W.W., Perona-Wright G., Freeman M.L., Yager E.J., Connor L.M., et al. Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection. Journal of Experimental Medicine 2011, 208:1621-1634.
81. Kurachi M., Kurachi J., Suenaga F., Tsukui T., Abe J., Ueha S., et al. Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration. Journal of Experimental Medicine 2011, 208:1605-1620.
82. Hu J.K., Kagari T., Clingan J.M., Matloubian M. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:E118-E127.
83. Schwarz J.B., Langwieser N., Langwieser N.N., Bek M.J., Seidl S., Eckstein H.H., et al. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. Circulation Research 2009, 104:189-200.